Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:55 PM
Study NCT ID:
NCT03414658
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2017-11-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
Sponsor:
Adrienne G. Waks
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-10
First Submit QC Date:
None
Study First Post Date:
2018-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-20
Results First Submit QC Date:
None
Results First Post Date:
2024-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-24
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL